BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9299593)

  • 1. RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways.
    Elmazar MM; Rühl R; Reichert U; Shroot B; Nau H
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):21-8. PubMed ID: 9299593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist.
    Elmazar MM; Rühl R; Nau H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):2-9. PubMed ID: 11141350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
    Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
    J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo.
    Eckhardt K; Schmitt G
    Toxicol Lett; 1994 Feb; 70(3):299-308. PubMed ID: 8284797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
    Kochhar DM; Jiang H; Penner JD; Beard RL; ChandraratnaAS
    Chem Biol Interact; 1996 Mar; 100(1):1-12. PubMed ID: 8599851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid X receptor-selective ligands produce malformations in Xenopus embryos.
    Minucci S; Saint-Jeannet JP; Toyama R; Scita G; DeLuca LM; Tiara M; Levin AA; Ozato K; Dawid IB
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1803-7. PubMed ID: 8700839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of specific retinoid receptors in sebocyte growth and differentiation in culture.
    Kim MJ; Ciletti N; Michel S; Reichert U; Rosenfield RL
    J Invest Dermatol; 2000 Feb; 114(2):349-53. PubMed ID: 10651997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
    Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
    Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells.
    Koo JS; Jetten AM; Belloni P; Yoon JH; Kim YD; Nettesheim P
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):351-7. PubMed ID: 10024510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of involvement of retinoic acid receptor alpha in retinoid-induced skin irritation in hairless mice.
    Standeven AM; Teng M; Chandraratna RA
    Toxicol Lett; 1997 Aug; 92(3):231-40. PubMed ID: 9334834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.
    Melino G; Draoui M; Bellincampi L; Bernassola F; Bernardini S; Piacentini M; Reichert U; Cohen P
    Exp Cell Res; 1997 Aug; 235(1):55-61. PubMed ID: 9281352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.